Topical Delivery of Vitamin D3: a Randomized Controlled Pilot Study

Overview

Journal Int J Biomed Sci

Specialty General Medicine

Date 2014 Apr 9

PMID 24711745

Citations 10

Authors

Mir Sadat-Ali

Dalal A Bubshait

Haifa A Al-Turki

Dakheel A Al-Dakheel

Wissam S Al-Olayani

Affiliations

Soon will be listed here.

Abstract

Background And Objective: The purpose of the present study is to explore the assessment if the transdermal delivery of vitamin D is feasible.

Methods: In 50 female Medical students, this study was conducted. Age, weight and height was taken, a detailed history and clinical examination was performed. Blood was drawn for 25 Hydroxy Vitamin D3 (25OHD) level. Two women had >30 ng/mL of 25OHD and was excluded from the study. The participants were divided into two groups of 24 in each arm. All participants equivocally agreed not to change their dietary habits and life style till the study was over. The study group of women were asked to apply; Top-D (Aloe Vera based- Vitamin D3) (Patency Pending) was developed at King Fahd Hospital of the University, AlKhobar with each gram of the Top-D cream delivering 5000 IU of vitamin D3. The second group used 1 gram of Aloe vera gel. The participants had no knowledge to which group they belong. A second blood sample was taken at the end of 3 months and the data was analyzed.

Results: The data of 48 women was available for analysis. The average age was 22.58 ± 1.95 years. The mean pre-treatment 25OHD in the study group was 12.05 ng/Ml ± 6.54 and post-treatment was 37.95 ng/mL ± 6.43 (P=0.001, CI<28.582 ). In control group pre-treatment 25OHD was 11.4 ng/mL ± 3.97 and post-treatment was 10.58ng/mL ± 3.03.

Conclusions: This randomized control study shows that vitamin D3 can safely be delivered through the dermal route. This route could be exploited in treating vitamin D deficiency.

Citing Articles

Can the use of vitamin D-fortified sunscreen cream be the solution to the vitamin D deficiency pandemic?.

Kara H, Polat U, Baykan O, Selcuk E, Turan G Arch Dermatol Res. 2025; 317(1):348.

PMID: 39912957 DOI: 10.1007/s00403-025-03837-4.

Evaluation of the safety, tolerability and plasma vitamin D response to long-term use of patented transdermal vitamin D patches in healthy adults: a randomised parallel pilot study.

Jefferson A, Borges C BMJ Nutr Prev Health. 2023; 5(2):217-226.

PMID: 36619342 PMC: 9813629. DOI: 10.1136/bmjnph-2022-000471.

Prevalence of Postoperative Micronutrient Deficiencies in Bariatric Surgery Patients Who Use Transdermal Patches for Supplementation: A Pilot Study.

Culpepper T, Lux T, Trivedi S, Neal D, Hazen K, Fleisher M Cureus. 2022; 14(6):e25989.

PMID: 35859973 PMC: 9287997. DOI: 10.7759/cureus.25989.

Efficacy of transdermal delivery of liposomal micronutrients through body oil massage on neurodevelopmental and micronutrient deficiency status in infants: results of a randomized placebo-controlled clinical trial.

Apte A, Kapoor M, Naik S, Lubree H, Khamkar P, Singh D BMC Nutr. 2021; 7(1):48.

PMID: 34493339 PMC: 8524365. DOI: 10.1186/s40795-021-00458-8.

Peeking into the future: Transdermal patches for the delivery of micronutrient supplements.

Grammatikopoulou M, Gkiouras K, Dardiotis E, Zafiriou E, Tsigalou C, Bogdanos D Metabol Open. 2021; 11:100109.

PMID: 34337377 PMC: 8318979. DOI: 10.1016/j.metop.2021.100109.

References

Grant A, Avenell A, Campbell M, McDonald A, MacLennan G, McPherson G . Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005; 365(9471):1621-8. DOI: 10.1016/S0140-6736(05)63013-9. View

Diez A, Carbonell C, Calaf J, Caloto M, Nocea G . Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain. Menopause. 2011; 19(1):89-95. DOI: 10.1097/gme.0b013e318223bd6b. View

Ahad A, Al-Jenoobi F, Al-Mohizea A, Aqil M, Kohli K . Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv. 2013; 10(8):1137-53. DOI: 10.1517/17425247.2013.783562. View

Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G . Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996; 49(4):255-9. DOI: 10.1007/BF00226324. View

Elsammak M, Al-Wosaibi A, Al-Howeish A, Alsaeed J . Vitamin d deficiency in Saudi Arabs. Horm Metab Res. 2010; 42(5):364-8. DOI: 10.1055/s-0030-1248296. View

Al-Turki H, Sadat-Ali M, Al-Elq A, Al-Mulhim F, Al-Ali A . 25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med J. 2008; 29(12):1765-8. View

Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T . Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005; 330(7498):1003. PMC: 557150. DOI: 10.1136/bmj.330.7498.1003. View

Sedrani S, Elidrissy A, El Arabi K . Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr. 1983; 38(1):129-32. DOI: 10.1093/ajcn/38.1.129. View

. The classic. De rachitide sive marbo puerili, qui vulgo the rickets dicitur: Francis Glisson, M.D. Clin Orthop Relat Res. 1973; (93):4-9. DOI: 10.1097/00003086-197306000-00002. View

10.

Aggarwal N, Goindi S . Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol. 2013; 9(4):564-76. DOI: 10.1166/jbn.2013.1569. View

11.

Segal E, Zinman C, Raz B, Ish-Shalom S . Low patient compliance--a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily. Arch Gerontol Geriatr. 2009; 49(3):364-7. DOI: 10.1016/j.archger.2008.12.001. View

12.

Hernigou P . Historical overview of rickets, osteomalacia, and vitamin D. Rev Rhum Engl Ed. 1995; 62(4):261-70. View

13.

Al-Elq A . The status of Vitamin D in medical students in the preclerkship years of a Saudi medical school. J Family Community Med. 2012; 19(2):100-4. PMC: 3410172. DOI: 10.4103/2230-8229.98293. View

14.

Castelo-Branco C, Cortes X, Ferrer M . Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric. 2009; 13(6):578-84. DOI: 10.3109/13697130903452804. View

15.

Sanfelix-Genoves J, Gil-Guillen V, Orozco-Beltran D, Giner-Ruiz V, Pertusa-Martinez S, Reig-Moya B . Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009; 26(10):861-9. DOI: 10.2165/11317070-000000000-00000. View

16.

Kruse W, Koch-Gwinner P, Nikolaus T, Oster P, Schlierf G, Weber E . Measurement of drug compliance by continuous electronic monitoring: a pilot study in elderly patients discharged from hospital. J Am Geriatr Soc. 1992; 40(11):1151-5. DOI: 10.1111/j.1532-5415.1992.tb01806.x. View

17.

Sedrani S . Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab. 1984; 28(3):181-5. DOI: 10.1159/000176801. View

18.

Jackson R, LaCroix A, Gass M, Wallace R, Robbins J, Lewis C . Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354(7):669-83. DOI: 10.1056/NEJMoa055218. View

19.

Shi Y, Wei Z, Zhao H, Liu T, Dong A, Zhang J . Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J Nanosci Nanotechnol. 2013; 13(6):3855-63. DOI: 10.1166/jnn.2013.7157. View

20.

Sadat-Ali M, Alelq A, Al-Turki H, Al-Mulhim F, Al-Ali A . Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009; 29(5):378-82. PMC: 3290044. DOI: 10.4103/0256-4947.55168. View